Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other InitiativesAUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Board of Directors has appointed Richard (Rick) Barry as Executive Chairman of the Board and as the Company’s principal executive officer, effective immediately. The Company is undertaking a search for a new permanent CEO.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXGSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
MDXG LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MDXG
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MiMedx Group, Inc. (
NASDAQMDXG) resulting from allegations that MiMedx may have issued materially misleading business information to the investing public.
MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the FirmNEW YORK, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MiMedx Group, Inc. (“MiMedx” or the “Company”) (
NASDAQMDXG) on behalf of MiMedx stockholders. Our investigation concerns whether MiMedx has violated the federal securities laws and/or engaged in other unlawful business practices.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of MiMedx Group, Inc. (“MiMedx” or the “Company”) (
NASDAQMDXG) investors concerning the Company’s possible violations of the federal securities laws.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of MiMedx Group, Inc. (“MiMedx” or the “Company”) (
NASDAQMDXG) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of MiMedx Group, Inc. (“MiMedx” or the “Company”) (
NASDAQMDXG) on behalf of investors concerning the Company’s possible violations of federal securities laws.
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III StudyMediWound to join forces with leading chronic wound allograft company in pivotal study for patients with venous leg ulcers
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales GrowthMiMedx Group, Inc. (
NASDAQMDXG) is engaged as a biotechnology company that is focused as a placental biologics developer to
